Expected Moves

Estimated announcement for the fiscal quarter ending September 2026. The focus will be on whether the recent 25.3% revenue and explosive 864% net income growth can be sustained into the second half of the year.

Expected mid-winter update on shareholder returns. With a massive $8.67B cash pile and zero debt against a $14.1B market cap, pressure from the Tokyo Stock Exchange to improve capital efficiency is reaching a tipping point.

Japan's Ministry of Health, Labour and Welfare (MHLW) typically reviews and revises medical device and testing reimbursement rates ahead of the new fiscal year in April.

Full-year results and the critical initial management guidance for FY2028. Global macro demand and the stability of the US labor market (unemployment currently 4.1%) will factor into their export forecasts.